leadf
logo-loader
TSX-V:IPA

ImmunoPrecise Antibodies Ltd

Receive alerts
Market:
TSX-V
Market Cap:
$195.14 m
Price
2.44 CAD
Change
15.64%
52 weeks high
3.14
52 weeks low
0.50

In brief

ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials.

Snapshot

The biotech company is the world’s only single source contract resource organization to offer the full complement of antibody discovery platforms

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Biopharmaceuticals battling COVID-19 pandemic to connect with investors via Proactive One2One Investor Forum on September 10

Shareholders and others will have the opportunity to engage with CEOs from AIM ImmunoTech, Heat Biologics, Avalon GloboCare, Oregenisis, and ImmunoPrecise Antibodies

on 9/9/20